Sectoral Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Sectoral Asset Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,300	Closed	-$257K	–	115
2022 Q2	$257K	Buy	+4,300	New	+$265K	0.05%	102
2021 Q2	–	Sell	-112,200	Closed	-$12.8M	–	132
2021 Q1	$12.8M	Buy	+112,200	New	+$15.3M	0.97%	38
2020 Q3	–	Sell	-8,600	Closed	-$673K	–	164
2020 Q2	$673K	Buy	+8,600	New	+$569K	0.06%	115
2019 Q1	–	Sell	-9,047	Closed	-$393K	–	111
2018 Q4	$393K	Hold	9,047	–	–	0.05%	70
2018 Q3	$691K	Buy	+9,047	New	+$736K	0.07%	79

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Sectoral Asset Management's RARE Position: Q3 2022 in Review

Sectoral Asset Management sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2022, closing a stake of 4,300 shares — an estimated $257K sold.

Sectoral Asset Management first reported a position in RARE in Q3 2018 and held it in 5 quarters. The position peaked at $12.8M in Q1 2021. 232 funds tracked by Wall St. Rank hold RARE as of Q3 2022.

Sectoral Asset Management reported no remaining Ultragenyx Pharmaceutical position as of Q3 2022 after selling out during the quarter.
Sectoral Asset Management sold 4,300 Ultragenyx Pharmaceutical shares in Q3 2022, an estimated $257K.
Sectoral Asset Management first reported a position in Ultragenyx Pharmaceutical in Q3 2018 and held it in 5 quarters.
Sectoral Asset Management's Ultragenyx Pharmaceutical position peaked at $12.8M in Q1 2021.
232 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2022.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.